Abstract

Ferroptosis is a type of iron-dependent regulated cell death, representing an emerging disease-modulatory mechanism. Transcription factors play multiple roles in ferroptosis, although the key regulator for ferroptosis in iron metabolism remains elusive. Using NanoString technology, we identify NUPR1, a stress-inducible transcription factor, as a driver of ferroptosis resistance. Mechanistically, NUPR1-mediated LCN2 expression blocks ferroptotic cell death through diminishing iron accumulation and subsequent oxidative damage. Consequently, LCN2 depletion mimics NUPR1 deficiency with respect to ferroptosis induction, whereas transfection-enforced re-expression of LCN2 restores resistance to ferroptosis in NUPR1-deficient cells. Pharmacological or genetic blockade of the NUPR1-LCN2 pathway (using NUPR1 shRNA, LCN2 shRNA, pancreas-specific Lcn2 conditional knockout mice, or the small molecule ZZW-115) increases the activity of the ferroptosis inducer erastin and worsens pancreatitis, in suitable mouse models. These findings suggest a link between NUPR1-regulated iron metabolism and ferroptosis susceptibility.

Ferroptosis is an iron-dependent form of oxidative cell death. In this study, the authors show that NUPR1, a stress-inducible transcription factor, may be a driver of ferroptosis resistance.

Details

Title
NUPR1 is a critical repressor of ferroptosis
Author
Liu, Jiao 1 ; Song, Xinxin 2 ; Kuang Feimei 1 ; Zhang, Qiuhong 3 ; Xie Yangchun 4 ; Kang, Rui 2 ; Kroemer Guido 5   VIAFID ORCID Logo  ; Tang Daolin 6   VIAFID ORCID Logo 

 Guangzhou Medical University, The Third Affiliated Hospital, Key Laboratory of Protein Modification and Degradation, Guangdong, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 UT Southwestern Medical Center, Department of Surgery, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 University of Pittsburgh, Department of Surgery, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000) 
 Central South University, Department of Oncology, The Second Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
 Sorbonne Paris Cité, Université Paris Descartes, Paris, France (GRID:grid.469994.f) (ISNI:0000 0004 1788 6194); Centre de Recherche des Cordeliers, Equipe 11 labellisée Ligue Nationale contre le Cancer, Paris, France (GRID:grid.417925.c); Institut National de la Santé et de la Recherche Médicale, Paris, France (GRID:grid.7429.8) (ISNI:0000000121866389); Université Pierre et Marie Curie, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Gustave Roussy Cancer Campus, Metabolomics and Cell Biology Platforms, Villejuif, France (GRID:grid.14925.3b) (ISNI:0000 0001 2284 9388); Hôpital Européen Georges Pompidou, AP-HP, Pôle de Biologie, Paris, France (GRID:grid.414093.b); Karolinska University Hospital, Department of Women’s and Children’s Health, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705) 
 Guangzhou Medical University, The Third Affiliated Hospital, Key Laboratory of Protein Modification and Degradation, Guangdong, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); UT Southwestern Medical Center, Department of Surgery, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2482358105
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.